Atossa Therapeutics (ATOS) Payables (2011 - 2026)
Atossa Therapeutics (ATOS) recorded Payables of $1.98 million in Q2 2026, down 1.7% from $2.01 million a year earlier and down 23.1% from the prior quarter.
Powered by 
Analysis
Atossa Therapeutics (ATOS) Payables (2011 - 2026) Analysis & Trends
At the end of FY2025, Atossa Therapeutics reported Payables of $4.29 million, up 532.3% from FY2024.
- Annual Payables has a five-year compound annual growth rate of 22.0% (FY2020 to FY2025).
- Across earlier years, Payables came in at $679,000 in FY2024 (-15.8%), $806,000 in FY2023 (-72.8%), $2.97 million in FY2022 (+72.7%) and $1.72 million in FY2021 (+8.1%).
- The Q2 2026 figure is the lowest quarterly Payables since Q1 2025.
- On a year-over-year basis, Payables rose in five of the last eight quarters, with growth averaging 120.5%.
- Peak year-over-year performance for Payables in the last five years was growth of 532.3% in Q4 2025, against a decline of 72.8% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.57 million (Q1 2026), $4.29 million (Q4 2025) and $3.54 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Atossa Therapeutics | 19.46 Mn | 19.46 Mn | - | 1.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.98 Mn |
| Mar 31, 2026 | 2.57 Mn |
| Dec 31, 2025 | 4.29 Mn |
| Sep 30, 2025 | 3.54 Mn |
| Jun 30, 2025 | 2.01 Mn |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 679,000.00 |
| Sep 30, 2024 | 1.56 Mn |
| Jun 30, 2024 | 1.06 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | 806,000.00 |
| Sep 30, 2023 | 718,000.00 |
| Jun 30, 2023 | 1.17 Mn |
| Mar 31, 2023 | 1.44 Mn |
| Dec 31, 2022 | 2.97 Mn |
| Sep 30, 2022 | 1.65 Mn |
| Jun 30, 2022 | 2.05 Mn |
| Mar 31, 2022 | 1.60 Mn |
| Dec 31, 2021 | 1.72 Mn |
| Sep 30, 2021 | 667,988.00 |
API Access
Atossa Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=ATOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "ATOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=ATOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();